These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 7244951)

  • 1. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.
    Fisher B; Wolmark N; Bauer M; Redmond C; Gebhardt M
    Surg Gynecol Obstet; 1981 Jun; 152(6):765-72. PubMed ID: 7244951
    [No Abstract]   [Full Text] [Related]  

  • 2. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures.
    Pigott J; Nichols R; Maddox WA; Balch CM
    Surg Gynecol Obstet; 1984 Mar; 158(3):255-9. PubMed ID: 6701738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
    Kuru B; Bozgul M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
    Ahlgren J; Holmberg L; Bergh J; Liljegren G
    Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial.
    Christensen SB; Jansson C
    Eur J Surg; 1993 Mar; 159(3):159-62. PubMed ID: 8102890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary carcinoma of the breast without axillary lymph node metastases.
    Fracchia AA; Rosen PP; Ashikari R
    Surg Gynecol Obstet; 1980 Sep; 151(3):375-8. PubMed ID: 7404307
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.
    Krishnamurthy S; Sneige N; Bedi DG; Edieken BS; Fornage BD; Kuerer HM; Singletary SE; Hunt KK
    Cancer; 2002 Sep; 95(5):982-8. PubMed ID: 12209680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The axillary lymph nodes in breast cancer. Seven years on.
    Steele RJ
    J R Coll Surg Edinb; 1983 Sep; 28(5):282-91. PubMed ID: 6358482
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sentinel lymph node biopsy in breast carcinoma. Can removal of the sentinel node replace axillary dissection?].
    Schalhorn B
    Fortschr Med; 1999 Feb; 117(5):22. PubMed ID: 10095307
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
    Friedman NS; Freedman MD
    Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of intramammary nodes in completion mastectomy specimens after axillary node sampling: implications for breast conserving surgery.
    Rampaul RS; Dale OT; Mitchell M; Blamey RW; Macmillan RD; Robertson JF; Ellis IO
    Breast; 2008 Apr; 17(2):195-8. PubMed ID: 18164619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is axillary lymph node dissection necessary in routine management of breast cancer? No.
    Cady B
    Important Adv Oncol; 1996; ():251-65. PubMed ID: 8791141
    [No Abstract]   [Full Text] [Related]  

  • 20. [-Breast neoplasms: axillary lymph node excision--at what price-].
    Rageth JC
    Arch Gynecol Obstet; 1995; 256 Suppl():S85-92. PubMed ID: 8619667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.